OWLT's fourth-quarter results are likely to reflect subscription growth, FDA-backed differentiation and revenue gains, even as tariff pressures weigh on margins.
OWLT is deepening healthcare partnerships to expand adoption beyond consumers, starting with hospital-prescribed monitoring and broader clinical use cases.
Remote and continuous patient monitoring is moving from a niche capability to a core pillar of modern healthcare, driven by aging populations, staffing shortages, and a push toward data-driven care both inside hospitals and at home. Against this backdrop, Owlet, Inc. OWLT and Masimo Corporation MASI represent two very different ways to invest in the same secular trend.
OWLT broadens its product ecosystem with new cameras, bundles and devices, aiming to boost adoption beyond the Dream Sock and drive growth.
OWLT benefits from FDA clarity, boosting credibility, raising barriers and supporting growth via subscriptions.
OWLT's 82% surge in the past six months is backed by record Q3 results, FDA leadership and growing subscription momentum.
OWLT's growing data flywheel and AI plans aim to deepen engagement, boost subscriptions, and extend customer value.
Owlet (OWLT) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Owlet (OWLT) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
If you are looking for stocks that are well positioned to maintain their recent uptrend, Owlet (OWLT) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Owlet (OWLT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Owlet, Inc. ( OWLT ) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants Jay Gentzkow - Vice President of Investor Relations Jonathan Harris - CEO & President Amanda Crawford - Chief Financial Officer Conference Call Participants Lucas Romanski - TD Cowen, Research Division Owen Rickert - Northland Capital Markets, Research Division Presentation Operator Good afternoon. Thank you for attending the Owlet Q3 '25 Earnings Conference Call.